5Chu CJ, Lee FY, Wang SS, et al. Hyperdynamic circulation of cirrhotic rats with ascites:role of endotoxin, tumor necrosis factor-alpha and nitric oxide. Clin Sci Colch, 1997, 93:219 - 225.
6Bielecka M, Biedrzycka E, Majkowska A, et al. Effect on non-digestible oligosaccharides on gut microecosystem in rats. Food Res Inter, 2002, 35:139 - 144.
7Nanji AA, Khettry U, Sadrzadeh SMH, et al. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med, 1994, 205:243 - 247.
8Murawaki Y, Kobayashi M, Koda M, et al. Effects of lactulose on intestinal bacterial flora and fecal organic acid in patients with liver cirrhosis. Hepatol Res, 2000, 17:56 - 64.
9Uchiahara M, Izumi N, Sato C, et al. Clinnical significance of elevated plasma endotoxin concentration in patients with cirrhosis. Hepatology, 1992, 16:95 - 99.
10Panes J, Perry MA, Anderson DC, et al. Portal hypertension enhance endotoxin-induced intercellular adhension moleculelup-regulation in the rat. Gastroenterology, 1996, 110: 866 - 874.
6Guerrero Hemández I,Torre Delgadillo A,Vargas Vorackova F. Intestinal flora,probiotics,and cirrhosis[J].{H}Annals of Hematology,2008,(2):120-124.
7Bajaj JS,Saeian K,Christensen KM. Probiotic yogurt for the treatment of minimal hepatic encephalopathy[J].{H}American Journal of Gastroenterology,2008,(7):1707-1715.
8Liu Q,Duan ZP,Ha DK. Synbiotic modulation of gut flora:effect on minimal hepatic encephalopathy in patients with cirrhosis[J].{H}HEPATOLOGY,2004,(5):1441-1449.
9Malaguarnera M,Gargante MP,Malaguarnera G. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy[J].{H}European Journal of gastroenterology & hepatology,2010,(2):199-206.
10Mittal VV,Sharma BC,Sharma P. A randomized controlled trial comparing lactulose,probiotics,and Lornithine L-aspartate in treatment of minimal hepatic encephalopathy[J].{H}European Journal of gastroenterology & hepatology,2011,(8):725-732.
